This is the quote the excites me, as it suggests technology will be extended out to other tumour types, beyond pancreatic....
“Designation of the OncoSil device as a breakthrough device is a validation of our platform technology which can be used to treat multiple solid tumour types such as liver, biliary duct and of course pancreatic cancer,”
This is the quote the excites me, as it suggests technology will...
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
-0.001(10.0%) |
Mkt cap ! $14.99M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.4¢ | $2.533K | 537.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 50 | 26286683 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 27731867 | 23 |
View Market Depth
| Last trade - 14.29pm 22/05/2024 (20 minute delay) ? |
|
|||||
|
Last
0.5¢ |
Change
-0.001 ( 25.0 %) |
||||
| Open | High | Low | Volume | ||
| 0.5¢ | 0.5¢ | 0.5¢ | 50000 | ||
| Last updated 12.34pm 22/05/2024 ? | |||||
| OSL (ASX) Chart |